TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,428,163 | -7.1% | 147,340 | -12.0% | 0.07% | -9.5% |
| Q4 2022 | $2,613,125 | +1401.8% | 167,508 | +1151.4% | 0.07% | +1133.3% |
| Q3 2022 | $174,000 | -73.8% | 13,386 | -71.7% | 0.01% | -80.0% |
| Q2 2022 | $664,000 | +45.3% | 47,273 | +41.0% | 0.03% | +7.1% |
| Q4 2021 | $457,000 | +69.3% | 33,525 | +122.4% | 0.03% | +47.4% |
| Q2 2020 | $270,000 | +21.6% | 15,076 | +34.1% | 0.02% | +46.2% |
| Q4 2019 | $222,000 | +21.3% | 11,243 | +5.5% | 0.01% | -18.8% |
| Q3 2019 | $183,000 | – | 10,654 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |